The optimal minimum lymph node count for carcinoembryonic antigen elevated colon cancer: a population-based study in the SEER set and External set

[1] Siegel R(2021)Cancer Statistics, 2021 CA Cancer J Clin 71 7-33

[2] Miller K(2018)Polypectomy versus surgery in early colon cancer: size and location of colon cancer affect long-term survival Int J Color Dis 33 1349-1357

[3] Fuchs H(2021)A Modified Tumor-Node-Metastasis Staging System for Colon Cancer Patients with Fewer than Twelve Lymph Nodes Examined World J Surg 45 2601-2609

[4] Jemal A(2006)Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer J Clin Oncol: official journal of the American Society of Clinical Oncology 24 3570-3575

[5] Gangireddy V(2021)Optimal examined lymph node count in node-negative colon cancer should be determined Future Oncol 17 3865-3872

[6] Coleman T(2018)NCCN Guidelines Insights: Colon Cancer, Version 2.2018 J Nat Comprehensive Cancer Network : JNCCN 16 359-369

[7] Kanneganti P(1965)Demonstration of tumor-specific antigens in humsn colonic carcinomata by immunological tolerance and absorption techniques J Exp Med 121 439-462

[8] Talla S(2005)Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer Cancer Investig 23 338-351

[9] Annapureddy A(2001)Prognostic value of carcinoembryonic antigen (CEA) in tumor tissue of patients with colorectal cancer Anticancer Res 21 3031-3036

[10] Amin R(1999)Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? Dis Colon Rectum 42 921-929

[1] Siegel R(2021)Cancer Statistics, 2021 CA Cancer J Clin 71 7-33

[2] Miller K(2018)Polypectomy versus surgery in early colon cancer: size and location of colon cancer affect long-term survival Int J Color Dis 33 1349-1357

[3] Fuchs H(2021)A Modified Tumor-Node-Metastasis Staging System for Colon Cancer Patients with Fewer than Twelve Lymph Nodes Examined World J Surg 45 2601-2609

[4] Jemal A(2006)Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer J Clin Oncol: official journal of the American Society of Clinical Oncology 24 3570-3575

[5] Gangireddy V(2021)Optimal examined lymph node count in node-negative colon cancer should be determined Future Oncol 17 3865-3872

[6] Coleman T(2018)NCCN Guidelines Insights: Colon Cancer, Version 2.2018 J Nat Comprehensive Cancer Network : JNCCN 16 359-369

[7] Kanneganti P(1965)Demonstration of tumor-specific antigens in humsn colonic carcinomata by immunological tolerance and absorption techniques J Exp Med 121 439-462

[8] Talla S(2005)Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer Cancer Investig 23 338-351

[9] Annapureddy A(2001)Prognostic value of carcinoembryonic antigen (CEA) in tumor tissue of patients with colorectal cancer Anticancer Res 21 3031-3036

[10] Amin R(1999)Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? Dis Colon Rectum 42 921-929